- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/75 - Fibrinogen
Patent holdings for IPC class C07K 14/75
Total number of patents in this class: 265
10-year publication summary
|
18
|
16
|
21
|
18
|
10
|
23
|
20
|
9
|
18
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| EpiVax, Inc. | 80 |
15 |
| Modernatx, Inc. | 1263 |
9 |
| Fibrex Medical Research & Development GmbH | 11 |
8 |
| CSL Behring GmbH | 344 |
6 |
| Octapharma AG | 202 |
6 |
| Osaka University | 3377 |
6 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 293 |
5 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3137 |
5 |
| Green Cross Holdings Corporation | 50 |
4 |
| Omrix Biopharmaceuticals Ltd. | 153 |
4 |
| Diadem Biotherapeutics, Inc. | 15 |
4 |
| Glaxosmithkline Biologicals S.A. | 1631 |
3 |
| Ethicon, Inc. | 1185 |
3 |
| Northwestern University | 3374 |
3 |
| Biotest AG | 114 |
3 |
| Cizzle Biotechnology Limited | 6 |
3 |
| CollPlant Ltd. | 48 |
3 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2799 |
3 |
| The Texas a & M University System | 1684 |
3 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1351 |
3 |
| Other owners | 166 |